Hospital volume and surgical mortality in the United States.

By J. Birkmeyer, A. Siewers, E. Finlayson, T. Stukel, F. L. Lucas, I. Batista, H. Welch, D. Wennberg. New England Journal of Medicine, 2002

2,618 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/a9c1286afe37b2238cfcd7ddef7c431865c85e86

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Peter D. Siersema
2. Rick A. Nishimura
3. Peter C. Austin
4. Joseph S. Alpert
5. C. Yancy
6. Roger Mundry

Citations in the corpus

• Systematic review finds overlapping reviews were not mentioned in every other overview. (2014, background): “For instance, a study investigating the volumeeoutcome relationship in surgery analyzed several procedures [15].”
• Recent progress in pancreatic cancer (2013, background): “However, the morbidity rate associated with the pancreaticoduodenectomy has remained between 30% and 45%, even at high volume centers.(142) The most common postoperative morbid complication is delayed gastric emptying, occurring in 15% of patients, followed by wound infection (8%), pancreatic fistul”
• The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm (2018, background): “4% in high-volume hospitals (>79/ y).(440) Surgeon volume and prior dedicated vascular training also affect mortality of OSR.”
• Esophageal cancer. (2008, background): “less experienced surgeons, the mortality rate of esophageal resection may increase to above 20%.(28,29) The endoscopic treatment options for HGIN or early esophageal cancer include ablative therapies and endoscopic mucosal resection (EMR).”
• Hospital Volume and Late Survival After Cancer Surgery (2007, methodology): “For these reasons, we estimated total hospital volumes for each of the 6 procedures using methods previously described.(1) In brief, we used the 100% Medicare Inpatient file to determine the average number of procedures per year performed on Medicare patients by each hospital.”
• ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). (2004, background): “Birkmeyer et al (714) reviewed Medicare claims data for 6 cardiovascular and 8 cancer-related procedures.”
• Minimally Invasive Esophagectomy: Outcomes in 222 Patients (2003, background): “In a report summarizing nationwide statistics, the mortality rates from esophagectomy ranged from 8% in high-volume centers to as high as 23% in low-volume centers.(2) Given concerns over this high morbidity and mortality, patients with esophageal cancer may not even be referred for operation at all”
• Deliberate practice and the acquisition and maintenance of expert performance in medicine and related domains. (2004, background): “Analyses of millions of patients show that hospitals with a high volume of procedures have a higher treatment success than low-volume hospitals.(48) The superior results of high-volume hospitals may be due to many superior aspects of treatment, but there are demonstrations of an independent benefit ”
• Outcomes After Minimally Invasive Esophagectomy: Review of Over 1000 Patients (2012, neutral): “967 Photodynamic therapy 28 (6) 9 (2) 37 (4) 0.”
• The care of patients with an abdominal aortic aneurysm: the Society for Vascular Surgery practice guidelines. (2009, methodology): “Multiple reports have identified a strong relationship between outcomes following AAA repair and both hospital and individual surgeon case volume and experience.(101,259,262,268,269) For example, Birkmeyer and colleagues,(268) using national Medicare claims data and the Nationwide Inpatient Sample 1”
• Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence (2014, background): “…adjuvant chemotherapy for colorectal and breast cancer (Hershman et al, 2006; Lohrisch et al, 2006), hospital and surgeon volume of cancer surgery (Birkmeyer et al, 2002; Derogar et al, 2013), and the extent of lymph node harvest in colorectal cancer (Chen and Bilchik, 2006; Johnson et al, 2006).”